Absorbable Nasal Implants Market global sales are expected to grow at a CAGR of 7.2% from 2023 to 2032 | insightSLICE
The global Absorbable Nasal Implants market size was estimated to be US$ 550 million in 2021 and is expected grow at a CAGR of 7.2% between 2023 to 2032.
Nasal airway obstruction can be caused by several things, such as a deviated septum, enlarged turbinates, and weakened upper and/or lower lateral nasal wall cartilage, which can lead to nasal valve collapse or vestibular stenosis. Stuffiness and difficulty breathing through one or both nostrils are signs of nasal valve collapse.
Access the sample report: https://www.insightslice.com/request-sample/55
Over 80% of the overall airway resistance is caused by the nasal valve collapsing. Around 1 million treatments are performed to relieve the symptoms of nasal blockage, and over 3 million Americans contact a doctor about it.
Absorbable nasal implants enable improved breathing, help the patient sleep, and help alleviate nasal obstructions and blockages.
The key players of the Global Absorbable Nasal Implants Market are:
Acclarent, Inc., ArthroCare Corporation, Intersect ENT, Inc., Mentor Worldwide LLC, Pfizer, Inc., Smith & Nephew, Inc., Spirox, Inc., and Stryker Corporation are a few of the leading market participants for absorbable nasal implants that are covered in this report.
Key business tactics used by participants in the absorbable nasal implant market include product launches, an increase in clinical trials, competitive acquisitions and acquisitions, alliances, collaborations, and R&D activities.
Benefits of Absorbable Nasal Implants:
Nasal valve collapse has a severe negative impact on the patient’s quality of life. Some patients may have a severe case of this illness, which would limit the number of available treatments. The bulk of available treatments are also invasive, and nasal valve surgery is the sole effective cure.
In addition to training from either a facial plastic surgeon or an ENT expert, this requires wide skills. The nasal valve dilatation product, such as the Breathe Right strips, is one of the most popular choices. Regarding nasal valve dilators, there are two possibilities.
One is externally attached to the other that can be used within the nose. The alternative treatment for a collapsed nasal valve is rhinoplasty, either with or without grafts. This nasal problem is either undiagnosed and untreated or underdiagnosed as a result of inadequate patient awareness.
Read more about the report inclusions: https://www.insightslice.com/absorbable-nasal-implants-market
Factors responsible for growth of this market:
A non-invasive breathing device that supports the nasal cartilage and is absorbable can be referred to as a nasal implant. As current treatment methods for the septum and turbinate are insufficient for patients with nasal blockage, these implants represent an important developmental milestone.
Patients who have had rhinoplasty procedures tend to favour implants because there is a chance, they will have a nose that looks incredibly small. INEX and Latera are the two brands that are offered on the international market for absorbable nasal implants.
The Spirox Inc. product Latera is an absorbable nasal implant that was given FDA approval in 2016. The U.S. FDA approved INEX, the second absorbable nasal implant, in 2015.
Growth in the market for absorbable nasal implants is fuelled by the health advantages such as relief from nasal airway obstruction, improved breathing due to a clearer horizontal nasal passage, and reduced sleep disturbances, as well as the rising approval of gradual implantable devices by medical professionals like doctors.
However, stifling regulatory requirements, ingrained beliefs about implant discomfort, mild aching sensation, and, in rare cases, irritation are serving as the main barriers to the growth of the absorbable nasal implant market.
The Latera is a product developed to support the upper and lower lateral nasal cartilage, and the INEX is an absorbable nasal implant that supports septal cartilage. The copolymer used to create Latera is absorbed by the body over the course of more than 18 months.
The entire product consists of a delivery device and an accessory that places an implant in the correct place. The 16-gauge delivery cannula with a depth indicator and safety cover is included in the single-use delivery device together with a handle body, deployment plunger, and pushrod.
Since absorbable nasal implants are a novel product, there is a relatively tiny market for them, but they will be well received by doctors and patients who have a high degree of awareness.
Global Upper Body Ergometers Market: https://www.insightslice.com/upper-body-ergometers-market
Global Video Capillaroscopy Market: https://www.insightslice.com/video-capillaroscopy-market
Global Absorbable Nasal Implants Market Key Segments:
By Product Type:
- Drug-Eluting Implants
- Corticosteroid Eluting Implants
- Antibiotics Eluting Implants
- Non-Drug Eluting Implants
- Polymer Implant
- Carboxymethylcellulose (CMC) Implant
By End Use:
- Specialty clinics
- Ambulatory surgical centers
- North America
- United States
- Rest of North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Rest of South America
Geographic segmentation of the absorbable nasal implants market:
Geographically, the North American region dominated the market for absorbable nasal implants in 2020 and is expected to continue to do so between 2021 and 2026 due to significant investments made in research and development for effective treatment options for conditions like nasal airway obstruction with fewer side effects or the need for additional surgical procedures.
Proceed to purchase: https://www.insightslice.com/buy-now/55
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at email@example.com.
+1 707 736 6633